Results 81 to 90 of about 26,449 (239)

Combined application of Bacillus velezensis JDB15 and Trichoderma harzianum JDL4 suppresses banana Fusarium wilt under controlled conditions

open access: yesPest Management Science, EarlyView.
The surfactin C secreted by JDB15 and the probable parasitism of JDL4 lead to the leakage of intracellular macromolecules and the degradation of hyphae, respectively. Combined application of the two strains effectively controls banana Fusarium wilt under controlled conditions.
Deng Chen   +13 more
wiley   +1 more source

Structure of the lipopeptide vaccine candidates grouped according to the orientation of epitopes and Laa in the current study.

open access: yes, 2013
* Lipopeptide 1 (C16 Laa), Lipopeptide 2 (C14 Laa), Lipopeptide 3 (C12 Laa).
Michael F. Good (335348)   +6 more
core   +1 more source

Strain‐specific monitoring of Bacillus amyloliquefaciens AH2 in strawberry fields using a specific molecular marker

open access: yesPest Management Science, EarlyView.
A novel strain‐specific TaqMan quantitative polymerase chain reaction assay targeting the hsdM gene was developed to monitor Bacillus amyloliquefaciens AH2 in strawberries, providing a foundational tool to optimize biocontrol management. Abstract BACKGROUND The biocontrol agent Bacillus amyloliquefaciens AH2 is effective against Botrytis cinerea in ...
M Mercedes Maldonado‐González   +7 more
wiley   +1 more source

Synthetic and Mechanistic Studies with Lipopeptide Antibiotics [PDF]

open access: yes, 2018
The cyclic lipopeptides comprise a number of clinically relevant classes of antibiotics that date back from the discovery of the polymyxins in 1947 to the recent introduction of the lipoglycopeptides.
Afd Chemical Biology and Drug Discovery   +2 more
core  

Genotoxicity of cationic lipopeptide nanoparticles

open access: yesToxicology Letters, 2020
The genotoxicity of cationic lipopeptide nanoparticles (cLPNPs) was evaluated in vivo and in vitro comet assay and the in vivo chromosome aberrations test. In vitro comet assay, human blood cells were exposed to cLPNPs at the concentration of 2.5, 5, 10, 20, 40 and 100 μg/mL.
Aliy K. Zhanataev   +7 more
openaire   +3 more sources

Peptide‐based antibacterial nanoplatforms: Design principles, stimuli‐regulated behaviors, and applications

open access: yesResponsive Materials, EarlyView.
Peptide‐based antibacterial nanoplatforms, encompassing self‐assembled peptides and peptide‐engineered inorganic, polymeric, and lipid nanocarriers, are systematically reviewed. The article highlights design principles and stimuli‐responsive regulation for improving peptide stability, delivery efficiency, and antibacterial performance.
Peng Tan   +8 more
wiley   +1 more source

Effects of the lipopeptide mixture and water on the cell membranes of mycelia.

open access: yes, 2016
The concentration of the lipopeptide mixture was 100 μm/mL. a: Mycelia treated with water; b: mycelia treated with lipopeptide mixture; c: relative conductivity of B. dothidea mycelia grown in PDB amended with 100 μm/mL of lipopeptide mixture.
Xunhang Li (3095232)   +5 more
core   +1 more source

Mechanism‐Guided Engineering of Upconversion Nanoparticles for Antibacterial Phototherapy: From Photonic Principles to Translational Nanosystems

open access: yesSmall, EarlyView.
This review provides a systematic overview of the field of antibacterial PhotoDynamic Therapy (aPDT) triggered by upconversion nanoparticles (UCNPs), focusing on the mechanisms and the key factors that define their efficacy for generating bactericidal species upon NIR‐light activation.
Zhe Li   +3 more
wiley   +1 more source

Biosurfactant properties of lipopeptide-producing Bacillus species.

open access: yes, 2018
Biosurfactant properties of lipopeptide-producing Bacillus species.
Günter Brader (43018)   +6 more
core   +1 more source

Optimization transgene expression of short fully synthesized lipopeptide-based transfection agent for non-viral gene delivery vehicle [PDF]

open access: yes, 2018
Gene therapy using non-viral gene delivery vehicle might be applied for the treatment of viral infection, cancer and genetic disorders. However, the most challenging barrier is the low efficiency of transgene expression.
Kartasasmita, Rahmana E.   +15 more
core   +3 more sources

Home - About - Disclaimer - Privacy